These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7622770)

  • 21. Biomarkers for epithelial ovarian cancers.
    Mahata P
    Genome Inform; 2006; 17(2):184-93. PubMed ID: 17503391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic dysregulation in thyroid neoplasia.
    Kondo T; Asa SL; Ezzat S
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):389-400, ix. PubMed ID: 18502333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The biology of ovarian cancer.
    Auersperg N; Edelson MI; Mok SC; Johnson SW; Hamilton TC
    Semin Oncol; 1998 Jun; 25(3):281-304. PubMed ID: 9633841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer.
    Cooke IE; Shelling AN; Le Meuth VG; Charnock ML; Ganesan TS
    Genes Chromosomes Cancer; 1996 Apr; 15(4):223-33. PubMed ID: 8703848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
    Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
    Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical tumour markers in ovarian cancer.
    Mazurek A; Nikliński J; Laudański T; Pluygers E
    Eur J Cancer Prev; 1998 Feb; 7(1):23-35. PubMed ID: 9511849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and treatment of epithelial ovarian cancer.
    Schwartz PE
    Minerva Ginecol; 2003 Aug; 55(4):315-26. PubMed ID: 14581856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
    Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
    Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression and prognostic significance in ovarian cancer.
    Tammela J; Odunsi K
    Minerva Ginecol; 2004 Dec; 56(6):495-502. PubMed ID: 15729202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: functional similarity to the human disease and identification of prospective tumoral markers and targets.
    Urzúa U; Roby KF; Gangi LM; Cherry JM; Powell JI; Munroe DJ
    J Cell Physiol; 2006 Mar; 206(3):594-602. PubMed ID: 16245302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour.
    O'Neill CJ; McBride HA; Connolly LE; Deavers MT; Malpica A; McCluggage WG
    Histopathology; 2007 May; 50(6):773-9. PubMed ID: 17493241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas.
    Colitti CV; Rodabaugh KJ; Welch WR; Berkowitz RS; Mok SC
    Oncogene; 1998 Jan; 16(4):555-9. PubMed ID: 9484846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
    Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
    Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular abnormalities in epithelial ovarian tumors: present and future].
    Vaurs-Barrière C; Penault-Llorca F
    Bull Cancer; 2001 Aug; 88(8):741-51. PubMed ID: 11578942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p16 overexpression: a potential early indicator of transformation in ovarian carcinoma.
    Shigemasa K; Hu C; West CM; Clarke J; Parham GP; Parmley TH; Korourian S; Baker VV; O'Brien TJ
    J Soc Gynecol Investig; 1997; 4(2):95-102. PubMed ID: 9101469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian cancer of epithelial origin--an update.
    Menczer J
    Isr J Med Sci; 1993 Aug; 29(8):477-83. PubMed ID: 8407278
    [No Abstract]   [Full Text] [Related]  

  • 38. An update on the diagnosis and treatment of common malignant ovarian tumors.
    Gallup DG
    J Med Assoc Ga; 1997 Sep; 86(3):181-5. PubMed ID: 9293169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
    Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
    Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovarian cancer.
    Boyd ME
    Can J Surg; 1985 Mar; 28(2):114-6, 118. PubMed ID: 3971233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.